Certified by Founder Lodge
ALSA Ventures
United Kingdom - London, London
INVESTOR
1 Disclosed Funding Rounds $16,370,899
1 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
ALSA Ventures is a life science venture capital investor, focused on early stage novel therapeutics. With a strong operations background in drug development, our team seeks to bring together
| Company | Date | Round | Raised |
|---|---|---|---|
 Epsilogen Ltd |
September, 10 ,2024 | Series B | $16,370,899 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Poetiq | $45,800,000 | (Feb 3, 2026)
1Buy.AI | $3,900,000 | (Feb 3, 2026)
Principle | $2,000,000 | (Feb 3, 2026)
Prenosis | $20,000,000 | (Feb 3, 2026)
PranaX | $17,000,000 | (Feb 3, 2026)
